Article
Cited 4 time in 
Cited 4 time in 
Cited 4 time in
Metadata Downloads
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Johnson, C. Bryce | - |
| dc.contributor.author | Wrangle, John | - |
| dc.contributor.author | Mehrotra, Shikhar | - |
| dc.contributor.author | Li, Zihai | - |
| dc.contributor.author | Paulos, Chrystal M. | - |
| dc.contributor.author | Cole, David J. | - |
| dc.contributor.author | Surh, CD | - |
| dc.contributor.author | Rubinstein, Mark P. | - |
| dc.date.accessioned | 2017-07-19T13:49:01Z | - |
| dc.date.available | 2017-07-19T13:49:01Z | - |
| dc.date.created | 2017-02-27 | - |
| dc.date.issued | 2016-05 | - |
| dc.identifier.issn | 2162-402X | - |
| dc.identifier.uri | https://oasis.postech.ac.kr/handle/2014.oak/37659 | - |
| dc.description.abstract | IL-7 and IL-15 are critical for supporting T cells transferred into a lymphopenic environment. As activated CD8(+) T cells downregulate IL-7R alpha, it is thought IL-15 is more important. However, we find that CD8(+) T cells activated with IL-12 have elevated IL-7R alpha and rely on IL-7 for persistence and antitumor immunity. | - |
| dc.language | English | - |
| dc.publisher | TAYLOR & FRANCIS INC | - |
| dc.relation.isPartOf | ONCOIMMUNOLOGY | - |
| dc.title | Harnessing the IL-7/IL-7R alpha axis to improve tumor immunotherapy. | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1080/2162402X.2015.1122865 | - |
| dc.type.rims | ART | - |
| dc.identifier.bibliographicCitation | ONCOIMMUNOLOGY, v.5, no.5 | - |
| dc.identifier.wosid | 000379162200024 | - |
| dc.date.tcdate | 2019-02-01 | - |
| dc.citation.number | 5 | - |
| dc.citation.title | ONCOIMMUNOLOGY | - |
| dc.citation.volume | 5 | - |
| dc.contributor.affiliatedAuthor | Surh, CD | - |
| dc.identifier.scopusid | 2-s2.0-84964627091 | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.description.wostc | 3 | - |
| dc.description.scptc | 2 | * |
| dc.date.scptcdate | 2018-05-121 | * |
| dc.type.docType | Editorial Material | - |
| dc.subject.keywordAuthor | Adoptive cellular therapy | - |
| dc.subject.keywordAuthor | CD8 | - |
| dc.subject.keywordAuthor | IL-7 | - |
| dc.subject.keywordAuthor | IL-7Ra | - |
| dc.subject.keywordAuthor | IL-15 | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Immunology | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalResearchArea | Immunology | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Communities & Collection
Related Researcher
- SURH CHARLES DSURH, CHARLES D
- Div of Integrative Biosci & Biotech